JNJ

J&J may nab surgical robotics company Auris Health
J&J may nab surgical robotics company Auris Health
Mass Device
devices
M&A
JNJ
Auris Health
robotic surgery
Flag link:
J&J CEO: We Know We Still Have More Work to Do [in Devices]
J&J CEO: We Know We Still Have More Work to Do [in Devices]
Medical Devices and Diagnostics Industry
JNJ
earnings
devices
Alex Gorsky
Flag link:
J&J, Attorneys General Settle Hip Implant Allegations for $120m
J&J, Attorneys General Settle Hip Implant Allegations for $120m
RAPS.org
JNJ
DePuy
hip implants
metal-on-metal hip implants
Flag link:
Discounting hit J&J's Xarelto hard. Can a new launch turn things around?
Discounting hit J&J's Xarelto hard. Can a new launch turn things around?
Fierce Pharma
JNJ
earnings
Xarelto
Flag link:
Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year
Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year
CNBC
JNJ
earnings
Flag link:
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
AbbVie
JNJ
Imbruvica
pancreatic cancer
clinical trials
Flag link:
Johnson & Johnson Is Trying to Recover From Plunge
Johnson & Johnson Is Trying to Recover From Plunge
Investopedia
JNJ
earnings
Flag link:
Apple and Johnson & Johnson collaborating on heart research project
Apple and Johnson & Johnson collaborating on heart research project
Marketwatch
Apple
JNJ
Janssen
atrial fibrillation
Apple Watch
wearables
devices
Flag link:
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Janssen
JNJ
Erleada
prostate cancer
Europe
Flag link:
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
Janssen
JNJ
Erleada
prostate cancer
Flag link:
J&J hikes US prices for a basket of drugs, including certain top-sellers
J&J hikes US prices for a basket of drugs, including certain top-sellers
Endpoints
JNJ
drug pricing
Flag link:
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
JNJ
Pfizer
Eli Lilly
Jamie Dimon
Amazon
JPMHC 2019
Flag link:
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
JNJ
JPMHC 2019
immunology
psoriasis
Tremfya
Flag link:
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Portola Pharmaceuticals
AndexXa
Pfizer
Bristol-Myers Squibb
JNJ
Bayer
FDA
anticoagulant reversal
Flag link:
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Flag link:
Judge refuses to overturn $4.7 billion talc powder verdict
Judge refuses to overturn $4.7 billion talc powder verdict
Yahoo/AP
JNJ
ovarian cancer
Flag link:
Johnson & Johnson tries to win back trust from investors with 5-billion-dollar share repurchase program
Johnson & Johnson tries to win back trust from investors with 5-billion-dollar share repurchase program
GoinPharma
JNJ
share repurchase
Flag link:
J&J hits back over asbestos in talc claims
J&J hits back over asbestos in talc claims
Pharmaforum
JNJ
asbestos
Flag link:
J&J stock tumbles after Reuters reports it hid asbestos in talc
J&J stock tumbles after Reuters reports it hid asbestos in talc
Fierce Pharma
JNJ
Flag link:
Report: J&J willing to pay more than $400m to settle Pinnacle hip cases
Report: J&J willing to pay more than $400m to settle Pinnacle hip cases
Mass Device
JNJ
devices
Pinnacle Hip
Flag link:

Pages